Wu Yingjen Jeffrey, Pagel Michael A, Muldoon Leslie L, Fu Rongwei, Neuwelt Edward A
Department of Neurology, Oregon Health & Sciences University, Portland, OR, U.S.A.
Veterans Administration Medical Center, Portland, OR, U.S.A.
Anticancer Res. 2017 Aug;37(8):4029-4040. doi: 10.21873/anticanres.11788.
BACKGROUND/AIM: Brain metastases commonly occur in patients with malignant skin, lung and breast cancers resulting in high morbidity and poor prognosis. Integrins containing an αv subunit are cell adhesion proteins that contribute to cancer cell migration and cancer progression. We hypothesized that high expression of αv integrin cell adhesion protein promoted metastatic phenotypes in cancer cells.
Cancer cells from different origins were used and studied regarding their metastatic ability and intetumumab, anti-αv integrin mAb, sensitivity using in vitro cell migration assay and in vivo brain metastases animal models.
The number of brain metastases and the rate of occurrence were positively correlated with cancer cell αv integrin levels. High αv integrin-expressing cancer cells showed significantly faster cell migration rate in vitro than low αv integrin-expressing cells. Intetumumab significantly inhibited cancer cell migration in vitro regardless of αv integrin expression level. Overexpression of αv integrin in cancer cells with low αv integrin level accelerated cell migration in vitro and increased the occurrence of brain metastases in vivo.
αv integrin promotes brain metastases in cancer cells and may mediate early steps in the metastatic cascade, such as adhesion to brain vasculature. Targeting αv integrin with intetumumab could provide clinical benefit in treating cancer patients who develop metastases.
背景/目的:脑转移瘤常见于恶性皮肤癌、肺癌和乳腺癌患者,导致高发病率和不良预后。含有αv亚基的整合素是细胞粘附蛋白,有助于癌细胞迁移和癌症进展。我们假设αv整合素细胞粘附蛋白的高表达促进癌细胞的转移表型。
使用来自不同来源的癌细胞,通过体外细胞迁移试验和体内脑转移动物模型研究其转移能力以及抗αv整合素单克隆抗体intetumumab的敏感性。
脑转移瘤的数量和发生率与癌细胞αv整合素水平呈正相关。高表达αv整合素的癌细胞在体外显示出比低表达αv整合素的细胞显著更快的细胞迁移率。无论αv整合素表达水平如何,intetumumab在体外均能显著抑制癌细胞迁移。在低αv整合素水平的癌细胞中过表达αv整合素可加速体外细胞迁移并增加体内脑转移瘤的发生率。
αv整合素促进癌细胞脑转移,并可能介导转移级联反应的早期步骤,如与脑血管系统的粘附。用intetumumab靶向αv整合素可为发生转移的癌症患者提供临床益处。